참고문헌
- Arditi JD, Venihaki M, Karalis KP, et al (2007). Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer. Horm Metab Res, 39, 9-13. https://doi.org/10.1055/s-2007-956518
- Arita Y, Kihara S, Ouchi N, et al (1999). Paradoxical decrease of an adipose specific protein, adiponectin in obesity. Biochem Biophys Res Commun, 257, 79-83. https://doi.org/10.1006/bbrc.1999.0255
- Brakenhielm E, Veitonmaki N, Cao R, et al (2004). Adiponectininduced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cellapoptosis. Proc Natl Acad Sci USA, 101, 2476-81. https://doi.org/10.1073/pnas.0308671100
- Chandran M, Phillips SA, Ciaraldi T, et al (2003). Adiponectin: more than just another fat cell hormone? Diab Care, 26, 2442-50. https://doi.org/10.2337/diacare.26.8.2442
- Chen DC, Chung YF, The YT, et al (2006). m Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett, 237, 109-14. https://doi.org/10.1016/j.canlet.2005.05.047
- Dal Maso L, Augustin LS, Karalis A, et al (2004). Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab, 89, 1160-3. https://doi.org/10.1210/jc.2003-031716
- Dieudonne MN, Bussiere M, Dos Santos E, et al (2006). Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun, 345, 271-9. https://doi.org/10.1016/j.bbrc.2006.04.076
- Fujisawa T, Endo H, Tomimoto A, et al (2008). Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut, 57, 1531-8. https://doi.org/10.1136/gut.2008.159293
- Fukumoto J, Otake T, Tajima O, et al (2008). Adiponectin and colorectal adenomas: Self Defense Forces Health Study. Cancer Sci, 99,781-6. https://doi.org/10.1111/j.1349-7006.2008.00745.x
- Goktas S, Yilmaz MI, Caglar K, et al (2005). Prostate cancer and adiponectin. Urology, 65, 1168-72. https://doi.org/10.1016/j.urology.2004.12.053
- Grossmann ME, Nkhata KJ, Mizuno NK, et al (2008). Effects of adiponectin on breast cancer cell growth and signaling. Br J Cancer, 29, 370-9.
- Hu E, Liang P, Spiegelman BM (1996). AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem, 3, 10697-703.
- Ishikawa M, Kitayama J, Kazama S, et al (2005). Plasma adiponectin and gastric cancer. Clin Cancer Res, 11, 466-7.
- Kang JH, Yu BY, Youn DS (2007). Relationship of serum adiponectin and resistin levels with breast cancer risk. J Korean Med Sci, 22, 117-21. https://doi.org/10.3346/jkms.2007.22.1.117
- Karaduman M, Bilici A, Ozet A, et al (2007). Tissue levels of adiponectin in breast cancer patients. Med Oncol, 24, 361-6. https://doi.org/10.1007/s12032-007-0021-0
- Kelesidis I, Kelesidis T, Mantzoros CS (2006). Adiponectin and cancer: a systematic review. Br J Cancer, 94, 1221-5. https://doi.org/10.1038/sj.bjc.6603051
- Kim AY, Lee YS, Kim KH, et al (2010). Adiponectin represses colon cancer cell proliferation via adipoR1- and -R2- mediated AMPK activation. Mol Endocrinol, 24, 1441-52. https://doi.org/10.1210/me.2009-0498
- Kumor A, Daniel P, Pietruczuk M, et al (2009). Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Dis, 24, 275-278. https://doi.org/10.1007/s00384-008-0605-y
- Mantzoros C, Petridou E, Dessypris N, et al (2004). Adiponectin and breast cancer risk. J Clin Endocrinol Metab, 89, 1102-7. https://doi.org/10.1210/jc.2003-031804
- Matsuzawa Y, Funahashi T, Nakamura T (1999). Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte derived bioactive substances. Ann N Y Acad Sci, 892, 146-54. https://doi.org/10.1111/j.1749-6632.1999.tb07793.x
- Miyoshi Y, Funahashi T, Kihara S, et al (2003). Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res, 9, 5699-704.
- Okamoto Y, Kihara S, Ouchi N, et al (2002). Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation, 106, 2767-70. https://doi.org/10.1161/01.CIR.0000042707.50032.19
- Otake S, Takeda H, Suzuki Y, et al (2005). Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res, 11, 3642-6. https://doi.org/10.1158/1078-0432.CCR-04-1868
- Petridou E, Mantzoros C, Dessypris N, et al (2003). Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J Clin Endocrinol Metab, 88, 993-7. https://doi.org/10.1210/jc.2002-021209
- Schlienger JL, Luca F, Vinzio S, et al (2009). Obesity and cancer. Rev Med Interne, 30, 776-82. https://doi.org/10.1016/j.revmed.2009.04.007
- Sugiyama M, Takahashi H, Hosono K, et al (2009). Adiponectin inhibits colorectal cancer cell growth through the AMPK/ mTOR pathway. Int J Oncol, 34, 339-44.
- Takahata C, Miyoshi Y, Irahara N, et al (2007). Demonstration of Adiponectin Receptors 1 and 2 mRNA expression in human breast cancer cells. Cancer Lett, 250, 229-36. https://doi.org/10.1016/j.canlet.2006.10.006
- Tian YF, Chu CH, Wu MH, et al (2007). Anthropometric measures, plasma adiponectin, and breast cancer risk. Endocr Relat Cancer, 14, 669-677. https://doi.org/10.1677/ERC-06-0089
- Tworoger SS, Eliassen AH, Kelesidis T, et al (2007). Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab, 92, 1510-6. https://doi.org/10.1210/jc.2006-1975
- Wei EK, Giovannucci E, Fuchs CS, et al (2005). Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst, 97, 1688-94. https://doi.org/10.1093/jnci/dji376
- Weyer C, Funahashi T, Tanaka S, et al (2001). Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab, 86, 1930-5. https://doi.org/10.1210/jc.86.5.1930
- Wolk A, Gridley G, Svensson M, et al (2001). A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control, 12, 13-21. https://doi.org/10.1023/A:1008995217664
- Yamauchi T, Kamon J, Ito Y, et al (2003). Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature, 423, 762-9. https://doi.org/10.1038/nature01705
피인용 문헌
- Equol, Adiponectin, Insulin Levels and Risk of Breast Cancer vol.14, pp.4, 2013, https://doi.org/10.7314/APJCP.2013.14.4.2191
- The Role of Adiponectin in Breast Cancer: A Meta-Analysis vol.8, pp.8, 2013, https://doi.org/10.1371/journal.pone.0073183
- Republished: Obesity and colorectal cancer vol.89, pp.1055, 2013, https://doi.org/10.1136/postgradmedj-2013-304701rep
- Obesity Related Adipokines and Colorectal Cancer: A Review and Meta-Analysis vol.15, pp.1, 2014, https://doi.org/10.7314/APJCP.2014.15.1.397
- Lack of any Prognostic Relationship between Adiponectin Receptor (Adipo R1/R2) Expression for Early/Advanced Stage Gastric Cancer vol.15, pp.11, 2014, https://doi.org/10.7314/APJCP.2014.15.11.4711
- Serum Adiponectin but not Leptin at Diagnosis as a Predictor of Breast Cancer Survival vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6137
- Body Mass Index Effects on Risk of Ovarian Cancer: A Meta-Analysis vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7665
- Association of Adiponectin Receptor (Adipo-R1/-R2) Expression and Colorectal Cancer vol.15, pp.21, 2014, https://doi.org/10.7314/APJCP.2014.15.21.9385
- Genotypes on the Association Between Alcohol Intake and Serum Adiponectin Levels Among Japanese Male Workers vol.38, pp.6, 2014, https://doi.org/10.1111/acer.12406
- Adipo-R1 and Adipo-R2 Expression in Colorectal Adenomas and Carcinomas vol.16, pp.1, 2015, https://doi.org/10.7314/APJCP.2015.16.1.367
- Obesity and Obese-related Chronic Low-grade Inflammation in Promotion of Colorectal Cancer Development vol.16, pp.10, 2015, https://doi.org/10.7314/APJCP.2015.16.10.4161
- Associations of Serum Isoflavone, Adiponectin and Insulin Levels with Risk for Epithelial Ovarian Cancer: Results of a Case-control Study vol.16, pp.12, 2015, https://doi.org/10.7314/APJCP.2015.16.12.4987
- Relationship of serum isoflavone, insulin and adiponectin levels with breast cancer risk vol.22, pp.5, 2015, https://doi.org/10.1007/s12282-013-0502-2
- Diets link metabolic syndrome and colorectal cancer development vol.37, pp.3, 2017, https://doi.org/10.3892/or.2017.5385
- Association of leptin, visfatin, apelin, resistin and adiponectin with clear cell renal cell carcinoma vol.13, pp.1, 2017, https://doi.org/10.3892/ol.2016.5408
- Serum adiponectin in breast cancer vol.97, pp.29, 2018, https://doi.org/10.1097/MD.0000000000011433
- Association of serum adiponectin with breast cancer vol.98, pp.6, 2019, https://doi.org/10.1097/MD.0000000000014359